Building Blocks
Esta sección contiene productos fundamentales para la síntesis de compuestos orgánicos y biológicos. Building blocks son los materiales de partida esenciales utilizados para construir moléculas complejas a través de diversas reacciones químicas. Desempeñan un papel crítico en el descubrimiento de fármacos, la ciencia de materiales y la investigación química. En CymitQuimica, ofrecemos una gama diversa de building blocks de alta calidad para apoyar sus investigaciones innovadoras y proyectos industriales, asegurando que tenga los componentes esenciales para una síntesis exitosa.
Subcategorías de "Building Blocks"
- Ácidos borónicos y derivados del ácido borónico(5.778 productos)
- Building Blocks quirales(1.243 productos)
- Building Blocks de hidrocarburos(6.097 productos)
- Building Blocks orgánicos(61.052 productos)
Se han encontrado 201390 productos de "Building Blocks"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-Amino-4-(3,4-difluorophenyl)-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]butan-1-one
CAS:Versatile small molecule scaffoldFórmula:C16H16F5N5OPureza:Min. 95%Peso molecular:389.32 g/mol1-(2-(Bromomethyl)phenyl)propan-2-one
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H11BrOPureza:Min. 95%Peso molecular:227.1 g/mol5,6-Dimethyl-1-benzofuran-3-carboxylic acid
CAS:Versatile small molecule scaffoldFórmula:C11H10O3Pureza:Min. 95%Peso molecular:190.19 g/mol[2-(4-Fluorophenoxymethyl)phenyl]boronic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C13H12BFO3Pureza:Min. 95%Peso molecular:246.04 g/mol[5-Fluoro-2-(oxolan-3-ylmethoxy)phenyl]boronic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C11H14BFO4Pureza:Min. 95%Peso molecular:240.04 g/mol4,8-Dichloroimidazo[1,5-a]quinoxaline
CAS:Versatile small molecule scaffoldFórmula:C10H5Cl2N3Pureza:Min. 95%Peso molecular:238.07 g/moltert-Butyl N-methyl-N-(pyrrolidin-2-ylmethyl)carbamate
CAS:Versatile small molecule scaffoldFórmula:C11H22N2O2Pureza:Min. 95%Peso molecular:214.3 g/mol[4-(Oxolan-3-ylmethoxy)phenyl]boronic acid
CAS:Versatile small molecule scaffoldFórmula:C11H15BO4Pureza:Min. 95%Peso molecular:222.05 g/mol[2-(But-3-en-1-yloxy)phenyl]boronic acid
CAS:Versatile small molecule scaffoldFórmula:C10H13BO3Pureza:Min. 95%Peso molecular:192.02 g/moltert-Butyl 4-(2-aminoethyl)-3,3-difluoropiperidine-1-carboxylate
CAS:Versatile small molecule scaffoldFórmula:C12H22F2N2O2Pureza:Min. 95%Peso molecular:264.31 g/moltert-Butyl 3,3-difluoro-4-(2-hydroxyethyl)piperidine-1-carboxylate
CAS:Versatile small molecule scaffoldFórmula:C12H21F2NO3Pureza:Min. 95%Peso molecular:265.3 g/mol3,3-difluoropiperidin-4-ol hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C5H10ClF2NOPureza:Min. 95%Peso molecular:173.6 g/mol2-(1-Chloroethyl)-5-methyl-1,3-oxazole
CAS:Versatile small molecule scaffoldFórmula:C6H8ClNOPureza:Min. 95%Peso molecular:145.59 g/mol(1-Methyl-2-oxo-butyl)-carbamic acid tert-butyl ester
CAS:Versatile small molecule scaffoldFórmula:C10H19NO3Pureza:Min. 95%Peso molecular:201.26 g/mol1-{1-[(tert-Butoxy)carbonyl]pyrrolidin-3-yl}-5-methyl-1H-1,2,3-triazole-4-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C13H20N4O4Pureza:Min. 95%Peso molecular:296.32 g/mol7-Phenyl-3H-pyrimido[4,5-d]pyrimidin-4-one
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C12H8N4OPureza:Min. 95%Peso molecular:224.2 g/mol6-(Azetidin-1-yl)pyridine-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H10N2O2Pureza:Min. 95%Peso molecular:178.19 g/mol3-(Piperidin-3-yl)butanoic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H17NO2Pureza:Min. 95%Peso molecular:171.24 g/mol6-(Methylsulfamoyl)pyridine-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C7H8N2O4SPureza:Min. 95%Peso molecular:216.22 g/mol6-Isopropoxynicotinamide
CAS:<p>6-Isopropoxynicotinamide is a drug that has shown efficacy in animal models for neurodegenerative diseases, such as prion diseases. It binds to specific proteins and inhibits the conformational change of the protein, thereby preventing the formation of amyloid plaques. This drug also prevents the conversion of alpha-helical proteins into beta-sheet structures, which are found in neuropathological conditions. 6-Isopropoxynicotinamide has been shown to have a pharmacokinetic profile that is long-term and effective at escalating doses, making it an ideal candidate for optimization against neurodegenerative diseases.</p>Fórmula:C9H12N2O2Pureza:Min. 95%Peso molecular:180.2 g/mol
![3-Amino-4-(3,4-difluorophenyl)-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC24424.webp&w=3840&q=75)
![[2-(4-Fluorophenoxymethyl)phenyl]boronic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC32511.webp&w=3840&q=75)
![[5-Fluoro-2-(oxolan-3-ylmethoxy)phenyl]boronic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC32775.webp&w=3840&q=75)
![4,8-Dichloroimidazo[1,5-a]quinoxaline](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC33143.webp&w=3840&q=75)
![[4-(Oxolan-3-ylmethoxy)phenyl]boronic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC39957.webp&w=3840&q=75)
![[2-(But-3-en-1-yloxy)phenyl]boronic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC40283.webp&w=3840&q=75)
![1-{1-[(tert-Butoxy)carbonyl]pyrrolidin-3-yl}-5-methyl-1H-1,2,3-triazole-4-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC48582.webp&w=3840&q=75)
![7-Phenyl-3H-pyrimido[4,5-d]pyrimidin-4-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FJDC48619.webp&w=3840&q=75)
